How to Future-Proof Your Company with Smarter IT Choices 
BOSS Zhipin Continues Share Repurchases: More than RMB340M in 2026 Under Buyback Program LBank Exchange Will List Kiba Inu (KIBA) on March 9, 2022
Internet City, Dubai–(Newsfile Corp. – March 8, 2022) – LBank Exchange, a global digital asset…
LBank Exchange Will List Lustcoins (LUST) on March 10, 2022
Internet City, Dubai–(Newsfile Corp. – March 8, 2022) – LBank Exchange, a global digital asset…
o9 Solutions Drives Digital Supply Chain Transformation at Berger Paints
BANGALORE, India–(BUSINESS WIRE)–o9 Solutions, a leading enterprise AI-powered platform provider for integrated business planning and…
Trellix and Gotara Announce Partnership to Close Cybersecurity Talent Gap
Company Invests in Women to Become the Premier Cybersecurity Workplace SAN JOSE, Calif.–(BUSINESS WIRE)–Trellix, the…
Cyxtera to Speak at Upcoming Investor Conferences
MIAMI–(BUSINESS WIRE)–$CYXT #colocation—Cyxtera (NASDAQ: CYXT), a global leader in data center colocation and interconnection services,…
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment
MELBOURNE, Australia, March 08, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, “Telix”, the…
Acerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva™
Conference Call to be Held on March 9, 2022 at 8:30am ET to Discuss Transaction…
Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2021 Financial Results
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Turning Point Therapeutics to Participate in 42nd Annual Cowen Healthcare Conference – Update
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
Ikena Oncology to Present Preclinical Findings on IK-930, a Novel TEAD Inhibitor at the 2022 American Association for Cancer Research (AACR) Annual Meeting
BOSTON, March 07, 2022 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology…
Inventiva reports its 2021 Full-Year Results: key milestones achieved with lanifibranor in NASH and cedirogant in psoriasis
Initiation of the NATiV3 Phase III clinical trial with lanifibranor in NASH Receipt of a…
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial and Business Highlights
Completed dosing in Phase 2a clinical trial of ETX-810 in subjects with diabetic peripheral neuropathic…
ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA
FDA approval supports corporate goal of plasma supply self-sufficiency and ongoing revenue growth Company positioned to…
Opiant Pharmaceuticals to Report Fourth Quarter 2021 Financial Results and Host Conference Call and Webcast on March 15, 2022
SANTA MONICA, Calif., March 07, 2022 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a…
John Lunger, of Adaptimmune, Joins Genocea Biosciences’ Board of Directors
CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical…
Hank Payments Becomes a Member of the North American Financial Data and Technology Associations (FDATA)
Toronto, Ontario–(Newsfile Corp. – March 7, 2022) – Hank Payments Corp. (TSXV: HANK) (“Hank” or the…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Rafael Holdings, Inc. (RFL) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of C3.ai, Inc. (AI) Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…